Interact to see
Advertisement
Advertisement
ANWPX vs FCGEX
ANWPX vs FCGEX Comparison
Open Charts ANWPX vs FCGEX
American Funds New Perspective A
Price$74.62
Change+$0.38 (+0.51%)
VolumeN/A
Net Assets162.64B
NYLI PineStone Global Equity
Price$22.16
Change+$0.13 (+0.59%)
VolumeN/A
Net Assets41.81M
ANWPX vs FCGEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ANWPX vs. FCGEX commentary
Dec 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWPX is a Buy and FCGEX is a Buy.
FUNDAMENTALS
Fundamentals
ANWPX has more cash in the bank: 163B vs. FCGEX (41.8M). ANWPX pays higher dividends than FCGEX: ANWPX (0.47) vs FCGEX (0.19). ANWPX was incepted earlier than FCGEX: ANWPX (53 years) vs FCGEX (9 years). FCGEX (1.71) is less costly to investors than ANWPX (0.73). ANWPX is a more actively managed with annual turnover of: 24.00 vs. FCGEX (19.00). ANWPX (6%) and FCGEX (6%) have equivalent initial investment costs. ANWPX has a lower initial minimum investment than FCGEX: ANWPX (250) vs FCGEX (15000). ANWPX annual gain was more profitable for investors over the last year : 11.61 vs. FCGEX (5.01). FCGEX return over 5 years is better than : 38.56 vs. ANWPX (25.01).
| ANWPX | FCGEX | ANWPX / FCGEX | |
| Total Expense Ratio | 0.73 | 1.10 | 66% |
| Annual Report Gross Expense Ratio | 0.73 | 1.71 | 43% |
| Fund Existence | 53 years | 9 years | - |
| Gain YTD | 19.192 | 14.590 | 132% |
| Front Load | 6% | 6% | 105% |
| Min. Initial Investment | 250 | 15000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163B | 41.8M | 389,952% |
| Annual Yield % from dividends | 0.47 | 0.19 | 257% |
| Returns for 1 year | 11.61 | 5.01 | 232% |
| Returns for 3 years | 44.28 | 28.61 | 155% |
| Returns for 5 years | 25.01 | 38.56 | 65% |
| Returns for 10 years | 92.95 | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement